Sign inJoin waitlistJoin the waitlist

Nancy Hardy

Medical Director, Cell Therapy & Graft Engineering Laboratories · Univ of Maryland Sch of Med

Credentials: · · ·

History

Cell Therapy & Graft Engineering Laboratories · Univ of Maryland Sch of Med
Present
Univ of Maryland Sch of Med
Present
University of Maryland Capital Region Health
Present

Duke University Hospital
2000–2002
National Institute of Allergy and Infectious Diseases NIAID
1998–2000
Internal Medicine
Duke University Hospital
1995–1998
University of Washington School of Medicine
1991–1995
Carroll College (Helena, MT), History and Political Science
1987–1991

Research

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Nature Medicine · 2015 · 722 citations
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
Blood · 2013 · 500 citations
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Journal of Clinical Oncology · 2021 · 188 citations

Aaron Rapoport
36 papers
Jean Yared
31 papers
Saurabh Dahiya
25 papers
Mehmet Kocoglu
22 papers
Djordje Atanackovic
20 papers
Michael Bishop
16 papers
FL
Forat Lutfi
13 papers · 5 as a fellow
AB
Ali Bukhari
11 papers · 7 as a fellow
Ashraf Badros
11 papers
Madhurima Koka
10 papers
RG
Ronald Gress
10 papers
SL
Seung Lee
10 papers

Clinical trials

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2007–2013